Sukhi Thethy
Comptroller/Controller/Auditor en CHINOOK THERAPEUTICS, INC. .
Cargos activos de Sukhi Thethy
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Historial de carrera de Sukhi Thethy
Antiguos cargos conocidos de Sukhi Thethy.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Formación de Sukhi Thethy.
| San Jose State University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Sukhi Thethy
- Experiencia
